Information for Providers

Health Notices

  • Fluoroquinolones No Longer Recommended to Treat Gonorrhea
    MDH no longer recommends the use of fluoroquinolones (e.g. ciprofloxacin) for the treatment of gonococcal infections. MDH lab surveillance data from 2007 indicate high prevalence of quinolone resistance in isolates from heterosexuals (4.5%) as well as gay/bisexual men (28%).
  • Now Available from Lupin Pharmaceuticals: Cefixime (Suprax®) 400 mg Tablets for Treatment of Gonorrhea
    The CDC has announced the availability of oral cefixime (Suprax®) tablets from Lupin Pharmaceuticals for the treatment of uncomplicated urogenital and rectal gonococcal infections. This is the only CDC-recommended gonorrhea treatment available as a single-dose tablet. 
    Link to MMWR Attention: Non-MDH web link.
    CDC Dear Colleague Letter (PDF: 52KB/1 page)
    Information on obtaining cefixime tablets is available from Lupin by telephone (866-587-4617).

  • Increase in syphilis among gay/bisexual men in Minnesota

Tools and Resources

Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.

Updated Wednesday, September 10, 2014 at 03:56PM